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Introduction Materials and methods
One of the major problems in allograft trans­
plantation is rejection of the graft, as a result of 
an immune response mounted by the recipient 
against alloantigens expressed by the graft [ 1 ,2 ]. 
Owing to their unique anatomical position, endo­
thelial cells (ECs) are among the first cells of the 
allograft that are encountered by the recipient’s 
immune system. MHC class-I and class-II anti-
ECs and FBs
ECs and FBs were isolated from human umbili­
cal cord vein and foreskin fragments respectively 
as described previously [20]. Cells were serially 
subcultured under standard conditions. Passages 
3 to 15 were used; no influence of the passage 
number on the outcome of the experiments was 
observed.
gens expressed by the ECs may activate allo- 
reactive CD8 + and CD4+ T-lymphocyte subsets 
respectively [3-10]. T-cell activation requires 
not only engagement of the T-cell receptor-CD3 
complex, but also one or more co-stimulatoiy or 
accessory signals [11-16]. In several in vitro 
systems, the potent antigen-presenting and 
co-stimulatory capacities of ECs have been 
demonstrated [17-19]. In this study we have 
analysed the accessory signals involved in the 
proliferation of alloreactive peripheral blood 
T-lymphocytes induced by allogeneic MHC 
class-II molecules in vitro. Allogeneic MHC 
class-II molecules induced by treatment with 
interferon y (IFN-y) were presented by either 
ECs or fibroblasts (FBs). The expression of
Monocytes and T-cells
Monocytes and T-cells were isolated as
described previously [20-22]. Briefly, leucocyte- 
enriched cell suspensions were obtained from 
healthy volunteers by cytapheresis. Mononuclear 
cells were isolated from these suspensions by 
centrifugation on Ficoll (density 1.077 g/ml; 
Pharmacia, Uppsala, Sweden), and monocytes 
and lymphocytes were subsequently separated by 
counterflow centrifugation. T-cells were isolated 
from the lymphocyte fraction by rosetting with 
2-aminoethylisothiouronium bromide-treated 
sheep red blood cells. Monocytes as well as 
T-cells were cryopreserved in liquid nitrogen 
until use.
co-stimulatory molecules on both these cell types 
was compared. The T-cell-proliferation-inhibit- 
ing effect of a panel of antibodies directed 
against co-stimulatory molecules expressed by 
the ECs or against their counterstructures on the 
T-cells was assessed. Distinct inhibition of 
T-cell proliferation was observed with mono­
clonal antibodies (mAbs) directed against CD2,
lymphocyte-function-associated antigen (LFA)-3, 
LFA-1 or a combination of anti-[intercellular 
adhesion molecules (ICAM)-l and -2]. We con­
clude that CD2-LFA-3 and LFA-l-ICAM  inter­
actions are crucially involved in allogeneic
Allogeneic T-cell-proliferation assay
T-cells were cultured in 96-well U-bottomed
microtitre plates. Per incubation, 1.5 x 1 0 s
T-cells and 5.0 x lO 4 ECs or FBs were added. 
ECs and FBs were y-irradiated with 4000 rad 
before addition. In most experiments, HLA 
class-II expression was induced on ECs or FBs 
before use by a 3-day incubation with 200 units/ 
ml IFN-y (a gift from Boehringer-Ingelheim, 
Ingelheim, Germany). After 5 days of culture, 
T-cell proliferation was measured as [3H]thymi­
dine incorporation.
T-cell-EC interactions.
Antibodies
mAbs used for inhibition experiments and/or
Abbreviations used: EC, endothelial cell; IFN-y; inter­
feron y; FB, fibroblast; mAb, monoclonal antibody; 
ICAM, intercellular adhesion molecule; VCAM, vascu­
lar cell adhesion molecule; LFA, lymphocyte-function- 
associated antigen.
*To whom correspondence should be addressed.
immunofluorescence are listed in [20]. mAbs 
directed against adhesion molecules were 
selected for their capacity to block interactions 
between the adhesion molecule and its ligand. In 
inhibition experiments, mAbs were present 
during the entire duration of the E C -T -cell 
co-culture.
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Immunofluorescence
from flasks
non-enzymically. Cells were washed and incu­
bated with mAb at 0°C in suspension, stained 
with FITC-conjugated sheep anti-mouse anti­
body, and analysed using a flow cytometer.
Results
Analysis of antigen expression on human ECs and 
FBs before and after treatment with IFN-y
Expression of MHC class-I and class-II antigens 
and of co-stimulatoiy molecules was determined 
immunofluorescence 
metry analysis. Both 
MHC class-I antigens constitutively, and did not 
express class-II antigens. Treatment with IFN-y 
increased class-I antigen expression, especially
both ECs and FBs which was hardly affected by 
treatment with IFN-y. Vascular cell adhesion 
molecule (VCAM)-l and E-selectin were absent 
from all the cells tested, as was the B7/BB1 
molecule (results not shown). ICAM-1 was 
expressed on a subpopulation of untreated ECs 
and FBs, and was considerably up-regulated by 
treatment with IFN-y. ICAM-2 was constitutively 
expressed on ECs but not on FBs, and was not
by treatment with IFN-y not
Allogeneic HLA class-II antigen expression on ECs 
is necessary, but not sufficient for induction of 
T-cell proliferation
Both untreated and IFN-y-treated ECs and FBs 
were cultured in the presence of purified alloge-
on ECs, and induced a marked class-II antigen neic peripheral blood T-cells. T-cell proliferation 
expression on both ECs and FBs (Figure 1). The was determined for different combinations of
T-cell, FB and EC donors. A representative 
experiment is shown in Figure 2. Untreated ECs 
induced only marginal T-cells proliferation,
expression levels of HLA class-I and -II mole­
cules on IFN-y-treated FBs were somewhat 
lower than, but comparable with, those on IFN- 
y-treated ECs. The expression profiles of 
co-stimulatoiy molecules on ECs and FBs were 
very similar. LFA-3 had a low expression level on
ranging in these experiments between a 3- and 
38-fold increase in [3H]thymidine uptake as 
compared with T-cells alone. ECs treated with 
IFN-y, however, induced a 22- to 257-fold
increased T-cell proliferation. In contrast,
Analysis of MHC class-I (top) and class-II (bottom) 
expression on ECs (left) and FBs (right) as determined 
by indirect immunofluorescence followed by FACS
analysis
•  • «  # Cells stained with negative control antibody; i  p i #  "i  n •
untreated cells stained with anti-MHC antibodies; IFN-
y-treated cells (3 days; 200 units/ml) stained with anti-MHC 
antibodies.
Proliferation of purified peripheral blood T-lympho- 
cytes stimulated with untreated ECs and FBs, or with 
IFN-y-treated (3 days; 200 units/ml) ECs or FB (IFN-
EC and IFN-FB respectively)
T-cell proliferation is expressed as [1H]thymidine incorporated 
(c.p.m.).
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tested four different anti-CD44 mAbs in our 
model system. A modest inhibition (35%) could 
be observed with mAb 212.3, but not with the 
other three anti-CD44 mAbs. Whereas anti-LFA- 
1  mAbs were distinctly inhibitory (60-70%), 
anti-ICAM-1 inhibited no more than the control 
mAb. A somewhat higher inhibition was observed 
with anti-ICAM-2, whereas the combination of 
anti-ICAM-1 and -2 inhibited in an additive 
manner. A cocktail of mAbs directed against all
of the LFA-l/ICAM sion
couple, however, was no more inhibitory than the
anti-LFA-1 mAb alone.
Two mAbs against CD2 were
inhibitory up to 55-85%. This inhibition was, 
however, only partially mirrored by the inhibition 
obtained with mAbs directed against the endo­
thelial counterpart, LFA-3. mAbs directed 
against two alternative counterstructures of CD2, 
CD48 and CD59, were not inhibitory. Of the
third co-stimulatoiy couple investigated, VLA-
4/VCAM-l, only the anti-VLA-/? mAb was 
moderately inhibitory. Almost complete blockage 
of T-cell proliferation could be observed with a 
cocktail of all mAbs directed against adhesion 
molecules on the T-cell and, to a lesser extent, 
by blocking adhesion molecules on the endothe­
lial cells.
Discussion
Numerous aspects of EC-mediated activation of 
T-cells have
number of previous
in a
(reviewed in
[17-19]). Two types of interaction have to be
: those occurring 
and thoselogous
xenogeneic cells. rl 
have been the focus of attention during the past
autologous
few years. Several studies have 
importance of interactions between CD2 
LFA-3 molecules as a source of EC-derived 
co-stimulatory activity [22,28-30]. In the alloge 
neic situation, the interactions between lympho­
cytes and the endothelium are more complex, In 
vivo , they occur in vascularized allografts, where 
recipient lymphocytes enter the graft via the 
bloodstream, and encounter donor ECs. Via 
adhesion events probably similar to or identical 
with those taking place in inflammatory lympho- 
cyte-vessel wall interactions, 
endothelium will be 
extravasation into the allogeneic tissue. In addi­
tion to the molecular interactions that occur in 
the autologous situation, MHC class-I and class-
II antigens expressed by the vascular endo­
thelium may deliver initial activation and 
proliferation signals to recipient T-lymphocytes. 
The notion of T-cell activation by allogeneic ECs 
is supported by a large body of experimental
evidence [7,10,31-34]. In this study we investi­
gated the role of co-stimulatory molecules in the 
induction of allogeneic T-cell activation, using an 
in vitro co-culture system with human umbilical
ECs and purified peripheral
T -  „
Human FBs, induced by IFN-y to express 
MHC class II molecules, were unable to induce a 
T-eell response, confirming previously published 
data [35-37]. We therefore conclude that accès 
soiy signals, provided by ECs, play a crucial addi­
tional role. We
AOs.
the expression of
ICAM-1 and -2, YCAM-1, E-selectin, CD31, B7
and LFA-3 on untreated and IFN-y-treated ECs 
and FBs, and found that levels of expression on 
the two cell types were comparable, with the 
exception of ICAM-2. This might suggest that 
this alternative ligand for LFA-1 may have a 
specific function in the accessory function of 
ECs. Antibodies directed against ICAM-2 were 
indeed more inhibitory than anti-ICAM-1 mAbs
ation assay, but did not 
inhibit T-cell proliferation completely, suggest­
ing the existence of one or more additional, as 
yet unidentified, EC-specific factors. Our inhibi­
tion experiments further showed involvement of
CD2/LFA-3, but not
I TLA-4,
CD26 interactions in T-eell
of VLA-4/VCAM-1,
CD31/CD31 or
■ation induced
by allogeneic
in several
cells, confirming data
publications
[31,32,37-40]. In the case of VCAM-1, E-selectin
and B7, this is not surprising, since these mole­
cules are not expressed by either unstimulated or 
IFN-y-treated ECs. Taken together, our inhibi­
tion that both LFA-1-ICAM-1
2 , CD2-LFA-3 s play a ; m
of T-cells by ECs. Similar
itions to those ; m
in
*t were
we
in
T-cell
[22].
by anti-CD3
rress
i nve s 
block
m
of reagents that 
in EC-mediated 
of a cocktail of
anti-LFA-1 and anti-ICAM-1 mAbs could pro­
long indefinitely the survival of cardiac allografts
I - activation.
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between fully incompatible mouse strains [41]. 
Thurlow et al. [42] did not find any effect of 
anti-CD2 mAb administration on renal allograft 
rejections by humans, but cocktails of anti-CD2 
and anti-LFA-3 mAbs may have different effects. 
Recently, increased survival of cardiac allografts 
in a primate model achieved by administration of 
an LFA-3-Ig chimaeric molecule was reported 
by Kaplon et al. [43]. Further studies on the role 
of adhesion molecules in allograft rejection in 
experimental animals and in man may provide 
alternative strategies for rejection therapy 
besides the conventional immunosuppressive 
treatments aimed at the depletion of immuno­
competent T-cells.
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Non-conventional mechanisms of T-cell co-stimulation by endothelial cells
C. G. Orosz, D. Pidwell and P. W. Adams
Ohio State University College of Medicine, Department of Surgery/Transplant, Columbus, OH 43210, U.S.A.
Introduction
Lymphocyte-endothelial interactions are bidirec­
tional, complex and dynamic. Contact with 
T-cells can change endothelial behaviour [1], 
and contact with endothelial cells can change 
T-cell behaviour (reviewed in [2]). Studies in the 
latter area have focused primarily on the ability 
of endothelial cells to serve as alloantigen-pre- 
senting cells (APCs) for T-cells. This may have 
obscured other more subtle effects of endothelial 
cells on T-cell behaviour. We have developed 
gonadal vein endothelial cell (GVEC) lines from 
cadaver organ donors that can be obtained along
with
permits
autologous splenocytes
an examination of non-*
lymphocyte-endothelial interactions, 
experimental system, we have
re ne ie
a non-
conventional mechanism of T-cell co-stimulation 
that involves interleukin (IL)-2 and endothelial 
cell contact.
Methods
Cell populations
Peripheral blood mononuclear were
obtained from fresh heparinized blood, collected 
by venipuncture from normal individuals, iso­
lated using Ficoll-Hypaque gn 
recovered from the peripheral 
nuclear cell interface were washed three times in
mo 110-
Seligman’s (Gibco) i
in Dulbecco’s
Eagle’s medium [4].
Abbreviations used: AFC, alloantigen-presenting cell; 
GVEC, gonadal vein endothelial cell; IL, interleukin, 
mAb, monoclonal antibody; TNF-a, tumour necrosis 
factor a; sTNFR, soluble TNF receptor.
}- rriF-cells were isolated from peripheral
by negative selection,
CD3
blood mononuclear 
with a commercially available cocktail of mono­
clonal antibodies (mAbs) and C' (T Lympho- 
Kwik; One Lambda Inc., Canoga Park, CA, 
U.S.A.) using the methods of Clouse et al. [5]. 
In order to remove any remaining APCs, the cells 
were added to a 250 cm culture flask and incu­
bated with the flask on its side at 37°C under
10% for 45 min. Non-adherent cells were
t
1 x 10'Vml, and kept at 4°C
and to
use. Cells pre- 
stained >95%
imetric analysis, 
with undetectable levels of monocyte contamina­
tion (as verified by the absence of cells staining
or CD 14 and the inability to proliferate
hytohaemagglut
C f rriI’-cells were isolated from first-cycle
kwik-purifled CD3 I by treat
Lambda).
routinely
T-Lympho-kwik (One
manner
<
for CD4
contamination by
and undetectable levels of monocyte
contamination (as verified above).
GVK were gonadal
vein obtained from cadaveric donors and propa-
as previously described [3]. Cultures were
endothelial medium, 
(Gibco) supple- 
he at-inactivated
id, NY, U.S.A.) )
units/ml
buffer. Before use, all endothelial cell lines were 
characterized by flow cytometry for the surface
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